Predominant Promotion by Tacrolimus of Chondrogenic Differentiation to Proliferating Chondrocytes
Tacrolimus (FK506) has been used as a therapeutic drug beneficial for the treatment of rheumatoid arthritis in humans. In this study, we investigated the effects of FK506 on cellular differentiation in cultured chondrogenic cells. Culture with FK506 led to a significant and concentration-dependent i...
Saved in:
Main Authors: | Yukari Nakamura (Author), Takeshi Takarada (Author), Ayumi Kodama (Author), Eiichi Hinoi (Author), Yukio Yoneda (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2009-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Negative Correlation Between Per1 and Sox6 Expression During Chondrogenic Differentiation in Pre-chondrocytic ATDC5 Cells
by: Nguyen Quynh Le, et al.
Published: (2013) -
Glutamate Signaling System in Bone
by: Eiichi Hinoi, et al.
Published: (2004) -
A Negative Correlation Between Expression Profiles of Runt-Related Transcription Factor-2 and Cystine/Glutamate Antiporter xCT Subunit in Ovariectomized Mouse Bone
by: Kyosuke Uno, et al.
Published: (2011) -
Possible Modulation of Process Extension by N-Methyl-d-aspartate Receptor Expressed in Osteocytic MLO-Y4 Cells
by: Hiroyuki Fujita, et al.
Published: (2012) -
Selective Upregulation of Per1 mRNA Expression by ATP Through Activation of P2X7 Purinergic Receptors Expressed in Microglial Cells
by: Ryota Nakazato, et al.
Published: (2011)